SXTC (sxtchina.com) Rega marang bathi mangsa ngarep

Simbol resmi perusahaan China SXT Pharmaceuticals, Inc. (SXTC)

China SXT Pharmaceuticals (SXTC) production capacities are experiencing disruptions due to regular maintenance of extraction systems. Current price action helps track the impact of these factors, with the P/E ratio currently at 0.00. The business relies on the development of diverse medications, yet faces severe pressure from industry behemoths and the risks of government price controls within the crowded Eastern medicine segment.

China SXT Pharmaceuticals - Rasio kapitalisasi marang bathi mangsa ngarep SXTC (periode 04.07.2022 - 17.11.2026)

Ringkesan rincian data analitis sxtchina.com (SXTC)

Pambiji fundamental:China SXT Pharmaceuticals
Produk merek China SXT Pharmaceuticals

The production scale of traditional medicines at China SXT Pharmaceuticals (SXTC) is reflected in the dynamics of the company's forward P/E ratio. This metric compares the current market share price with the expected future earnings per share. The calculation determines the cost of a unit of future income, filtering out speculative market noise. Given the stable demand for herbal formulations, this approach confirms whether the asset is fundamentally undervalued or overheated. Investors utilize this indicator to assess the efficiency of cash flow generation.

Pesaing China SXT Pharmaceuticals

Rega marang bathi mangsa ngarep haleon.com (HLN)|KVUE (Kenvue Health) - Pangali mangsa ngarep rega marang bathi|Rega marang bathi mangsa ngarep Verona Pharma PLC VRNA|Jyong Biotech (MENS) - Rasio prakiraan rega marang bathi|LGND: Prakiraan rega marang bathi|Amneal - Rasio kapitalisasi marang bathi mangsa ngarep|PRGO: Pangali Forward P/E|Alvotech Corp - Pangali mangsa ngarep rega marang bathi|LQDA (Liquidia Corp) - Pangali Forward P/E|Rasio prakiraan rega marang bathi glpg.com GLPG|Rega marang bathi mangsa ngarep ANI Pharmaceuticals, Inc. (ANIP)|MNKD (MannKind Corp) - Pangali mangsa ngarep rega marang bathi|Pangali Forward P/E AMPH (Amphastar Pharmaceuticals Inc)|PCRX (Pacira) - Rasio rega marang bathi sing dikarepake|SPRY - Rega marang bathi mangsa ngarep|Pangali mangsa ngarep rega marang bathi TBPH (Theravance Biopharma)|AQST (aquestive.com) - Prakiraan rega marang bathi|Rasio rega marang bathi sing dikarepake SCPH (scPharmaceuticals, Inc.)|Prakiraan rega marang bathi TECX|Tonix Pharmaceuticals (TNXP) - Kapitalisasi marang proyeksi bathi|Pangali Forward P/E EPRX|Pangali Forward P/E bioharvest.com (BHST)|Rega marang bathi mangsa ngarep Invizyne Technologies EXOZ|ORMP: Rasio rega marang bathi mangsa ngarep|ENTX: Prakiraan rega marang bathi|HYFT: Rega marang bathi mangsa ngarep|ABVC BioPharma Inc. (ABVC) - Rega marang bathi mangsa ngarep|cumberlandpharma.com (CPIX) - Pangali Forward P/E|QNTM (Quantum BioPharma) - Pangali Forward P/E|FGEN: Pangali mangsa ngarep rega marang bathi|Pangali Forward P/E TELO|Pangali Forward P/E Rani Therapeutics Holdings (RANI)|Pangali Forward P/E SNYR (Synergy CHC Corp)|Rallybio Corporation (RLYB) - Rasio prakiraan rega marang bathi|LEXX - Rega marang bathi mangsa ngarep|PULM (Pulmatrix) - Rasio rega marang bathi mangsa ngarep|Pheton Holdings Ltd (PTHL) - Rega marang bathi mangsa ngarep|Aptorum - Pangali mangsa ngarep rega marang bathi|Prakiraan rega marang bathi LYRA|Prakiraan rega marang bathi Impact BioMedical Inc (IBO)|Pangali Forward P/E TNFA|YCBD: Rasio rega marang bathi sing dikarepake|Rega marang bathi mangsa ngarep PainReform PRFX|altamiratherapeutics.com (CYTO) - Rasio prakiraan rega marang bathi|LIPO: Prakiraan rega marang bathi|OPTN (optinose.com) - Rasio rega marang bathi mangsa ngarep|PIRS: Pangali Forward P/E|PROC - Kapitalisasi marang proyeksi bathi|PTPI (Petros Pharma) - Pangali Forward P/E|Rega marang bathi mangsa ngarep QLI|Pangali Forward P/E SLRN|Rasio kapitalisasi marang bathi mangsa ngarep TFFP